SCHEMBL6972004

SCHEMBL6972004

Cc1cn2c3cc(Br)ccc3c3cc(O)cc(c1=O)c32

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 2/20 0.34
LMNA P02545 2/20 0.33
PDGFRA P16234 1/20 0.33
CDK5 Q00535 1/20 0.33
TYRO3 Q06418 1/20 0.33
ESR2 Q92731 3/20 0.33
GSK3B P49841 1/20 0.32
MAPK8 P45983 1/20 0.32
ESR1 P03372 2/20 0.31
ESRRA P11474 1/20 0.31
ABCC2 Q92887 1/20 0.31
MAPT P10636 3/20 0.31
ALDH1A1 P00352 2/20 0.31
BRD4 O60885 1/20 0.31
TP53 P04637 1/20 0.31
THRB P10828 1/20 0.31
HCRTR1 O43613 1/20 0.31
POLB P06746 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CSNK2A2 P19784 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981368 0.89 LMNA (0.38) LMNAESR2GSK3BMAPK8ABCC2
SCHEMBL6978385 0.84 CYP19A1 (0.37) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL6979202 0.78 HSD17B3 (0.37) EGLN1ALDH1A1
SCHEMBL7971630 0.77 EGLN1 (0.33) EGLN1PDGFRACDK5TYRO3ESR2
SCHEMBL7084377 0.77 GABRA1 (0.32)
SCHEMBL6973743 0.75 PTGDR2 (0.31)
SCHEMBL6973159 0.74 GABRA1 (0.40) LMNAMAPTALDH1A1BRD4MEN1
SCHEMBL6977489 0.73 GABRA1 (0.41) ALDH1A1MEN1KMT2A
SCHEMBL6975262 0.73 PIK3R1 (0.38) LMNAMAPK8MAPTALDH1A1MEN1
SCHEMBL6979851 0.72 LMNA (0.41) LMNAMAPK8ALDH1A1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed